+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drug Device Combination Products Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

  • PDF Icon

    Report

  • 141 Pages
  • March 2022
  • Region: Global
  • IMARC Group
  • ID: 5562466
The global drug device combination products market reached a value of US$ 132.45 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 214.53 Billion by 2027, exhibiting at a CAGR of 8.27% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.



Drug device combination products comprise medical devices and pharmaceutical ingredients, which assist in delivering the drug to a specific location in the patient’s body. They include vaccine vials packaged with a delivery device, surgical trays with drapes and anesthetic swabs, and prefilled drug delivery systems like syringes, insulin injector pens, and metered dose inhalers. Some of the commonly available drug device combination products are monoclonal antibody combined with a therapeutic drug, pacing lead with steroid-coated tip, and catheter with an antimicrobial coating, and first-aid kits containing bandages and gauze are some.

Drug Device Combination Products Market Trends:


The growing prevalence of chronic diseases and the escalating demand for new approaches in treating diseases are among the key factors driving the adoption of drug device combination products across the globe. These products help patients suffering from cancer, heart disease, multiple sclerosis, cerebral palsy, spinal cord injuries, anemia, hepatitis, rheumatoid arthritis, diabetes, and other serious conditions. Moreover, these products offer advantages, such as minimal side effects, controlled drug administration, improved patient compliance, and targeted drug delivery. This, coupled with increasing preferences for smart and precision drug delivery systems that reduce the amount of drug required for therapeutic efficacy, is contributing to the market growth. Apart from this, market players are incorporating technologies into drug device combination products for tracking and monitoring purposes. They are also introducing sophisticated products made using complex active ingredients, formulations, routes of delivery, and dosage forms, such as peptides, liposomes, and transdermal. Additionally, they are focusing on developing next-generation products with high viscosity, formulations, and new classes of biologics. As a result, the demand for these products is anticipated to rise for providing patients treatments and solutions that can better adhere to their therapy.

Key Market Segmentation:


The publisher provides an analysis of the key trends in each sub-segment of the global drug device combination products market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, application and end user.

Breakup by Product:

  • Drug Eluting Stents
  • Transdermal Patches
  • Infusion Pumps
  • Drug Eluting Balloon
  • Inhalers
  • Others

Breakup by Application:

  • Cardiovascular
  • Diabetes
  • Cancer Treatment
  • Respiratory Diseases
  • Others

Breakup by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:


The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Baxter International Inc., Bayer AG, Becton Dickinson and Company, Boston Scientific Corporation, GlaxoSmithKline plc, Johnson & Johnson, Medtronic plc, Novartis AG, Smith & Nephew plc, Stryker Corporation and Terumo Corporation.

Key Questions Answered in This Report:


  • How has the global drug device combination products market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global drug device combination products market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global drug device combination products market and who are the key players?
  • What is the degree of competition in the industry?
Frequently Asked Questions about the Global Drug Device Combination Products Market

What is the estimated value of the Global Drug Device Combination Products Market?

The Global Drug Device Combination Products Market was estimated to be valued at $132.5 Billion in 2021.

What is the growth rate of the Global Drug Device Combination Products Market?

The growth rate of the Global Drug Device Combination Products Market is 8.3%, with an estimated value of $214.5 Billion by 2027.

What is the forecasted size of the Global Drug Device Combination Products Market?

The Global Drug Device Combination Products Market is estimated to be worth $214.5 Billion by 2027.

Who are the key companies in the Global Drug Device Combination Products Market?

Key companies in the Global Drug Device Combination Products Market include Abbott Laboratories, Baxter International Inc., Bayer AG, Becton Dickinson, Company, Boston Scientific Corporation, GlaxoSmithKline plc, Johnson & Johnson and Novartis AG.

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Drug Device Combination Products Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Drug Eluting Stents
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Transdermal Patches
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Infusion Pumps
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Drug Eluting Balloon
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Inhalers
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.2 Market Forecast
7 Market Breakup by Application
7.1 Cardiovascular
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Diabetes
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Cancer Treatment
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Respiratory Diseases
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Ambulatory Surgical Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Baxter International Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Bayer AG
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Becton Dickinson and Company
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Boston Scientific Corporation
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 GlaxoSmithKline plc
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Johnson & Johnson
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Medtronic plc
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Novartis AG
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Smith & Nephew plc
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Stryker Corporation
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Terumo Corporation
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
List of Figures
Figure 1: Global: Drug Device Combination Products Market: Major Drivers and Challenges
Figure 2: Global: Drug Device Combination Products Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Drug Device Combination Products Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Drug Device Combination Products Market: Breakup by Product (in %), 2021
Figure 5: Global: Drug Device Combination Products Market: Breakup by Application (in %), 2021
Figure 6: Global: Drug Device Combination Products Market: Breakup by End User (in %), 2021
Figure 7: Global: Drug Device Combination Products Market: Breakup by Region (in %), 2021
Figure 8: Global: Drug Device Combination Products (Drug Eluting Stents) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Drug Device Combination Products (Drug Eluting Stents) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Drug Device Combination Products (Transdermal Patches) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Drug Device Combination Products (Transdermal Patches) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Drug Device Combination Products (Infusion Pumps) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Drug Device Combination Products (Infusion Pumps) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Drug Device Combination Products (Drug Eluting Balloon) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Drug Device Combination Products (Drug Eluting Balloon) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Drug Device Combination Products (Inhalers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Drug Device Combination Products (Inhalers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Drug Device Combination Products (Other Products) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Drug Device Combination Products (Other Products) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Drug Device Combination Products (Cardiovascular) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Drug Device Combination Products (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Drug Device Combination Products (Diabetes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Drug Device Combination Products (Diabetes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Drug Device Combination Products (Cancer Treatment) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Drug Device Combination Products (Cancer Treatment) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Drug Device Combination Products (Respiratory Diseases) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Drug Device Combination Products (Respiratory Diseases) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Drug Device Combination Products (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Drug Device Combination Products (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Drug Device Combination Products (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Drug Device Combination Products (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Drug Device Combination Products (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Drug Device Combination Products (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Global: Drug Device Combination Products (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Global: Drug Device Combination Products (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: North America: Drug Device Combination Products Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: North America: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: United States: Drug Device Combination Products Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: United States: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Canada: Drug Device Combination Products Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Canada: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Asia-Pacific: Drug Device Combination Products Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Asia-Pacific: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: China: Drug Device Combination Products Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: China: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Japan: Drug Device Combination Products Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Japan: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: India: Drug Device Combination Products Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: India: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: South Korea: Drug Device Combination Products Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: South Korea: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Australia: Drug Device Combination Products Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Australia: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Indonesia: Drug Device Combination Products Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Indonesia: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Others: Drug Device Combination Products Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Others: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Europe: Drug Device Combination Products Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Europe: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Germany: Drug Device Combination Products Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Germany: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: France: Drug Device Combination Products Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: France: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: United Kingdom: Drug Device Combination Products Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: United Kingdom: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Italy: Drug Device Combination Products Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Italy: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Spain: Drug Device Combination Products Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Spain: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Russia: Drug Device Combination Products Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Russia: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Others: Drug Device Combination Products Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Others: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Latin America: Drug Device Combination Products Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Latin America: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Brazil: Drug Device Combination Products Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Brazil: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Mexico: Drug Device Combination Products Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Mexico: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Others: Drug Device Combination Products Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: Others: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Middle East and Africa: Drug Device Combination Products Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: Middle East and Africa: Drug Device Combination Products Market: Breakup by Country (in %), 2021
Figure 84: Middle East and Africa: Drug Device Combination Products Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Global: Drug Device Combination Products Industry: SWOT Analysis
Figure 86: Global: Drug Device Combination Products Industry: Value Chain Analysis
Figure 87: Global: Drug Device Combination Products Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Drug Device Combination Products Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Drug Device Combination Products Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 3: Global: Drug Device Combination Products Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 4: Global: Drug Device Combination Products Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 5: Global: Drug Device Combination Products Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Drug Device Combination Products Market: Competitive Structure
Table 7: Global: Drug Device Combination Products Market: Key Players

Companies Mentioned

  • Abbott Laboratories
  • Baxter International Inc.
  • Bayer AG
  • Becton Dickinson
  • Company
  • Boston Scientific Corporation
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Medtronic plc
  • Novartis AG
  • Smith & Nephew plc
  • Stryker Corporation
  • Terumo Corporation.

Methodology

Loading
LOADING...